Innovations in Transdermal Drug Delivery: Challenges, Approaches and Future Perspectives

Transdermal Drug Delivery Systems (TDDS) represent a promising approach for non-invasive drug administration, providing controlled and sustained release of therapeutic agents through the skin. This method offers several advantages over conventional delivery routes, such as avoiding first-pass metabolism, reducing systemic side effects, and improving patient compliance. However, the development of effective TDDS is challenging due to the skin's barrier function, primarily the stratum corneum, which restricts drug permeation. Recent innovations in formulation strategies, including matrix, reservoir, and drug-in-adhesive systems, have enhanced the efficiency of transdermal patches. Advanced permeation techniques such as microneedles, iontophoresis, ultrasound, and chemical enhancers have further expanded the range of drugs suitable for transdermal delivery, including peptides and macromolecules. Evaluation methods, including in vitro release studies, permeation tests, and in vivo pharmacokinetic analyses, are critical for optimizing drug formulations and ensuring safety and efficacy. The incorporation of novel technologies such as vesicular systems (liposomes, niosomes) and nanocarriers, alongside the development of smart, responsive transdermal systems, highlights the future potential of TDDS. This review explores recent advancements, formulation strategies, and challenges in transdermal drug delivery, providing insights into the innovative approaches that are shaping the next generation of transdermal therapeutics. Emphasis is placed on overcoming the limitations of current systems and enhancing drug permeation and patient adherence, aiming to expand the clinical applications of TDDS across various therapeutic areas.